Software - Application
Compare Stocks
5 / 10Stock Comparison
SPNS vs IBM vs ACN vs MSFT vs ORCL
Revenue, margins, valuation, and 5-year total return — side by side.
Information Technology Services
Information Technology Services
Software - Infrastructure
Software - Infrastructure
SPNS vs IBM vs ACN vs MSFT vs ORCL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Information Technology Services | Information Technology Services | Software - Infrastructure | Software - Infrastructure |
| Market Cap | $2.43B | $215.52B | $112.34B | $3.08T | $563.33B |
| Revenue (TTM) | $564M | $68.91B | $72.11B | $318.27B | $64.08B |
| Net Income (TTM) | $64M | $10.75B | $7.68B | $125.22B | $16.21B |
| Gross Margin | 44.3% | 59.0% | 32.0% | 68.3% | 66.4% |
| Operating Margin | 13.7% | 16.4% | 14.8% | 46.8% | 30.8% |
| Forward P/E | 27.9x | 18.5x | 13.0x | 24.8x | 26.2x |
| Total Debt | $64M | $67.15B | $8.18B | $112.18B | $104.10B |
| Cash & Equiv. | $164M | $13.64B | $11.48B | $30.24B | $10.79B |
SPNS vs IBM vs ACN vs MSFT vs ORCL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | Dec 25 | Return |
|---|---|---|---|
| Sapiens Internation… (SPNS) | 100 | 184.7 | +84.7% |
| International Busin… (IBM) | 100 | 258.7 | +158.7% |
| Accenture plc (ACN) | 100 | 124.0 | +24.0% |
| Microsoft Corporati… (MSFT) | 100 | 268.5 | +168.5% |
| Oracle Corporation (ORCL) | 100 | 375.6 | +275.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SPNS vs IBM vs ACN vs MSFT vs ORCL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SPNS is the #2 pick in this set and the best alternative if sleep-well-at-night and defensive is your priority.
- Lower volatility, beta 0.45, Low D/E 13.3%, current ratio 2.24x
- Beta 0.45, yield 1.3%, current ratio 2.24x
- Beta 0.45 vs ORCL's 1.58, lower leverage
- +53.4% vs ACN's -39.5%
IBM lags the leaders in this set but could rank higher in a more targeted comparison.
ACN ranks third and is worth considering specifically for income & stability.
- Dividend streak 14 yrs, beta 0.80, yield 3.2%
- Lower P/E (13.0x vs 26.2x), PEG 1.44 vs 3.69
- 3.2% yield, 14-year raise streak, vs IBM's 2.9%
MSFT carries the broadest edge in this set and is the clearest fit for growth exposure and valuation efficiency.
- Rev growth 14.9%, EPS growth 15.6%, 3Y rev CAGR 12.4%
- PEG 1.32 vs ORCL's 3.69
- 14.9% revenue growth vs SPNS's 5.4%
- 39.3% margin vs ACN's 10.7%
ORCL is the clearest fit if your priority is long-term compounding.
- 428.7% 10Y total return vs MSFT's 7.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 14.9% revenue growth vs SPNS's 5.4% | |
| Value | Lower P/E (13.0x vs 26.2x), PEG 1.44 vs 3.69 | |
| Quality / Margins | 39.3% margin vs ACN's 10.7% | |
| Stability / Safety | Beta 0.45 vs ORCL's 1.58, lower leverage | |
| Dividends | 3.2% yield, 14-year raise streak, vs IBM's 2.9% | |
| Momentum (1Y) | +53.4% vs ACN's -39.5% | |
| Efficiency (ROA) | 19.2% ROA vs IBM's 7.1%, ROIC 24.9% vs 9.8% |
SPNS vs IBM vs ACN vs MSFT vs ORCL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SPNS vs IBM vs ACN vs MSFT vs ORCL — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
SPNS leads in 2 of 6 categories
MSFT leads 1 • ACN leads 1 • ORCL leads 1 • IBM leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MSFT leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MSFT is the larger business by revenue, generating $318.3B annually — 564.0x SPNS's $564M. MSFT is the more profitable business, keeping 39.3% of every revenue dollar as net income compared to ACN's 10.7%. On growth, ORCL holds the edge at +21.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $564M | $68.9B | $72.1B | $318.3B | $64.1B |
| EBITDAEarnings before interest/tax | $93M | $15.1B | $12.1B | $192.6B | $26.5B |
| Net IncomeAfter-tax profit | $64M | $10.8B | $7.7B | $125.2B | $16.2B |
| Free Cash FlowCash after capex | $72M | $13.1B | $12.5B | $72.9B | -$24.7B |
| Gross MarginGross profit ÷ Revenue | +44.3% | +59.0% | +32.0% | +68.3% | +66.4% |
| Operating MarginEBIT ÷ Revenue | +13.7% | +16.4% | +14.8% | +46.8% | +30.8% |
| Net MarginNet income ÷ Revenue | +11.4% | +15.6% | +10.7% | +39.3% | +25.3% |
| FCF MarginFCF ÷ Revenue | +12.8% | +19.0% | +17.3% | +22.9% | -38.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +11.2% | +9.5% | +8.3% | +18.3% | +21.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -24.2% | +14.3% | +3.9% | +23.4% | +24.5% |
Valuation Metrics
ACN leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 14.8x trailing earnings, ACN trades at a 67% valuation discount to ORCL's 45.1x P/E. Adjusting for growth (PEG ratio), MSFT offers better value at 1.62x vs ORCL's 6.36x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.4B | $215.5B | $112.3B | $3.08T | $563.3B |
| Enterprise ValueMkt cap + debt − cash | $2.3B | $269.0B | $109.0B | $3.17T | $656.6B |
| Trailing P/EPrice ÷ TTM EPS | 33.68x | 20.57x | 14.85x | 30.43x | 45.15x |
| Forward P/EPrice ÷ next-FY EPS est. | 27.85x | 18.47x | 13.00x | 24.77x | 26.18x |
| PEG RatioP/E ÷ EPS growth rate | 1.69x | 1.66x | 1.65x | 1.62x | 6.36x |
| EV / EBITDAEnterprise value multiple | 22.11x | 17.53x | 8.61x | 19.46x | 27.53x |
| Price / SalesMarket cap ÷ Revenue | 4.48x | 3.19x | 1.61x | 10.94x | 9.81x |
| Price / BookPrice ÷ Book value/share | 5.09x | 6.66x | 3.54x | 9.02x | 26.78x |
| Price / FCFMarket cap ÷ FCF | 33.63x | 18.62x | 10.33x | 43.06x | — |
Profitability & Efficiency
SPNS leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
ORCL delivers a 56.3% return on equity — every $100 of shareholder capital generates $56 in annual profit, vs $13 for SPNS. SPNS carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to ORCL's 4.96x. On the Piotroski fundamental quality scale (0–9), SPNS scores 8/9 vs ACN's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +12.9% | +35.4% | +23.9% | +33.1% | +56.3% |
| ROA (TTM)Return on assets | +8.9% | +7.1% | +11.8% | +19.2% | +8.1% |
| ROICReturn on invested capital | +17.4% | +9.8% | +26.8% | +24.9% | +12.8% |
| ROCEReturn on capital employed | +16.9% | +9.5% | +24.9% | +29.7% | +14.4% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 5 | 5 | 6 | 6 |
| Debt / EquityFinancial leverage | 0.13x | 2.05x | 0.25x | 0.33x | 4.96x |
| Net DebtTotal debt minus cash | -$100M | $53.5B | -$3.3B | $81.9B | $93.3B |
| Cash & Equiv.Liquid assets | $164M | $13.6B | $11.5B | $30.2B | $10.8B |
| Total DebtShort + long-term debt | $64M | $67.2B | $8.2B | $112.2B | $104.1B |
| Interest CoverageEBIT ÷ Interest expense | 228.41x | 6.41x | 40.67x | 55.65x | 5.44x |
Total Returns (Dividends Reinvested)
ORCL leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ORCL five years ago would be worth $25,437 today (with dividends reinvested), compared to $7,076 for ACN. Over the past 12 months, SPNS leads with a +53.4% total return vs ACN's -39.5%. The 3-year compound annual growth rate (CAGR) favors ORCL at 27.6% vs ACN's -9.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | — | -20.0% | -29.3% | -12.0% | +0.6% |
| 1-Year ReturnPast 12 months | +53.4% | -6.3% | -39.5% | -4.5% | +31.7% |
| 3-Year ReturnCumulative with dividends | +100.9% | +103.8% | -25.4% | +37.6% | +107.9% |
| 5-Year ReturnCumulative with dividends | +64.0% | +88.3% | -29.2% | +73.8% | +154.4% |
| 10-Year ReturnCumulative with dividends | +301.1% | +108.0% | +90.1% | +776.0% | +428.7% |
| CAGR (3Y)Annualised 3-year return | +26.2% | +26.8% | -9.3% | +11.2% | +27.6% |
Risk & Volatility
SPNS leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
SPNS is the less volatile stock with a 0.45 beta — it tends to amplify market swings less than ORCL's 1.58 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SPNS currently trades 99.8% from its 52-week high vs ACN's 55.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.45x | 1.00x | 0.80x | 0.85x | 1.58x |
| 52-Week HighHighest price in past year | $43.52 | $324.90 | $325.71 | $555.45 | $345.72 |
| 52-Week LowLowest price in past year | $26.14 | $220.72 | $172.52 | $356.28 | $134.57 |
| % of 52W HighCurrent price vs 52-week peak | +99.8% | +70.7% | +55.4% | +74.7% | +56.7% |
| RSI (14)Momentum oscillator 0–100 | 69.6 | 43.9 | 41.9 | 57.9 | 68.7 |
| Avg Volume (50D)Average daily shares traded | 0 | 5.3M | 5.6M | 32.5M | 26.3M |
Analyst Outlook
Evenly matched — IBM and ACN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: SPNS as "Hold", IBM as "Hold", ACN as "Buy", MSFT as "Buy", ORCL as "Buy". Consensus price targets imply 66.2% upside for ACN (target: $300) vs -12.5% for SPNS (target: $38). For income investors, ACN offers the higher dividend yield at 3.24% vs MSFT's 0.78%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $38.00 | $309.64 | $299.92 | $556.88 | $257.09 |
| # AnalystsCovering analysts | 10 | 50 | 53 | 81 | 86 |
| Dividend YieldAnnual dividend ÷ price | +1.3% | +2.9% | +3.2% | +0.8% | +0.8% |
| Dividend StreakConsecutive years of raises | 1 | 30 | 14 | 19 | 18 |
| Dividend / ShareAnnual DPS | $0.57 | $6.59 | $5.85 | $3.23 | $1.65 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +4.1% | +0.6% | +0.3% |
SPNS leads in 2 of 6 categories (Profitability & Efficiency, Risk & Volatility). MSFT leads in 1 (Income & Cash Flow). 1 tied.
SPNS vs IBM vs ACN vs MSFT vs ORCL: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SPNS or IBM or ACN or MSFT or ORCL a better buy right now?
For growth investors, Microsoft Corporation (MSFT) is the stronger pick with 14.
9% revenue growth year-over-year, versus 5. 4% for Sapiens International Corporation N. V. (SPNS). Accenture plc (ACN) offers the better valuation at 14. 8x trailing P/E (13. 0x forward), making it the more compelling value choice. Analysts rate Accenture plc (ACN) a "Buy" — based on 53 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SPNS or IBM or ACN or MSFT or ORCL?
On trailing P/E, Accenture plc (ACN) is the cheapest at 14.
8x versus Oracle Corporation at 45. 1x. On forward P/E, Accenture plc is actually cheaper at 13. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Microsoft Corporation wins at 1. 32x versus Oracle Corporation's 3. 69x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — SPNS or IBM or ACN or MSFT or ORCL?
Over the past 5 years, Oracle Corporation (ORCL) delivered a total return of +154.
4%, compared to -29. 2% for Accenture plc (ACN). Over 10 years, the gap is even starker: MSFT returned +776. 0% versus ACN's +90. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SPNS or IBM or ACN or MSFT or ORCL?
By beta (market sensitivity over 5 years), Sapiens International Corporation N.
V. (SPNS) is the lower-risk stock at 0. 45β versus Oracle Corporation's 1. 58β — meaning ORCL is approximately 248% more volatile than SPNS relative to the S&P 500. On balance sheet safety, Sapiens International Corporation N. V. (SPNS) carries a lower debt/equity ratio of 13% versus 5% for Oracle Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — SPNS or IBM or ACN or MSFT or ORCL?
By revenue growth (latest reported year), Microsoft Corporation (MSFT) is pulling ahead at 14.
9% versus 5. 4% for Sapiens International Corporation N. V. (SPNS). On earnings-per-share growth, the picture is similar: International Business Machines Corporation grew EPS 73. 7% year-over-year, compared to 6. 2% for Accenture plc. Over a 3-year CAGR, MSFT leads at 12. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SPNS or IBM or ACN or MSFT or ORCL?
Microsoft Corporation (MSFT) is the more profitable company, earning 36.
1% net margin versus 11. 0% for Accenture plc — meaning it keeps 36. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MSFT leads at 45. 6% versus 14. 7% for ACN. At the gross margin level — before operating expenses — ORCL leads at 70. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SPNS or IBM or ACN or MSFT or ORCL more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Microsoft Corporation (MSFT) is the more undervalued stock at a PEG of 1. 32x versus Oracle Corporation's 3. 69x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Accenture plc (ACN) trades at 13. 0x forward P/E versus 27. 9x for Sapiens International Corporation N. V. — 14. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ACN: 66. 2% to $299. 92.
08Which pays a better dividend — SPNS or IBM or ACN or MSFT or ORCL?
All stocks in this comparison pay dividends.
Accenture plc (ACN) offers the highest yield at 3. 2%, versus 0. 8% for Microsoft Corporation (MSFT).
09Is SPNS or IBM or ACN or MSFT or ORCL better for a retirement portfolio?
For long-horizon retirement investors, Sapiens International Corporation N.
V. (SPNS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 45), 1. 3% yield, +301. 1% 10Y return). Oracle Corporation (ORCL) carries a higher beta of 1. 58 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SPNS: +301. 1%, ORCL: +428. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SPNS and IBM and ACN and MSFT and ORCL?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: SPNS is a small-cap quality compounder stock; IBM is a large-cap quality compounder stock; ACN is a mid-cap deep-value stock; MSFT is a mega-cap quality compounder stock; ORCL is a large-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.